Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic therapies for salivary gland cancer: Adenoid cystic carcinoma. REFCOR recommendations by the formal consensus method.
Ferrand FR, Even C, Chabrillac E, Thariat J, Fakhry N, Vergez S, Bensadoun RJ, Sarradin V, Digue L. Ferrand FR, et al. Among authors: even c. Eur Ann Otorhinolaryngol Head Neck Dis. 2023 Dec 6:S1879-7296(23)00161-8. doi: 10.1016/j.anorl.2023.11.009. Online ahead of print. Eur Ann Otorhinolaryngol Head Neck Dis. 2023. PMID: 38061943
Systemic therapies for salivary gland carcinoma (excluding adenoid cystic carcinoma): REFCOR recommendations by the formal consensus method.
Sarradin V, Digue L, Vergez S, Thariat J, Fakhry N, Chabrillac E, Bensadoun RJ, Ferrand FR, Even C. Sarradin V, et al. Among authors: even c. Eur Ann Otorhinolaryngol Head Neck Dis. 2023 Nov 30:S1879-7296(23)00156-4. doi: 10.1016/j.anorl.2023.11.004. Online ahead of print. Eur Ann Otorhinolaryngol Head Neck Dis. 2023. PMID: 38040592
Radiotherapy for salivary gland cancer: REFCOR recommendations by the formal consensus method.
Thariat J, Ferrand FR, Fakhry N, Even C, Vergez S, Chabrillac E, Sarradin V, Digue L, Troussier I, Bensadoun RJ. Thariat J, et al. Among authors: even c. Eur Ann Otorhinolaryngol Head Neck Dis. 2023 Nov 28:S1879-7296(23)00158-8. doi: 10.1016/j.anorl.2023.11.006. Online ahead of print. Eur Ann Otorhinolaryngol Head Neck Dis. 2023. PMID: 38030445
ESMO-EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease.
Bossi P, Chan AT, Even C, Machiels JP; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Bossi P, et al. Among authors: even c. Ann Oncol. 2023 Mar;34(3):247-250. doi: 10.1016/j.annonc.2022.11.011. Epub 2022 Dec 15. Ann Oncol. 2023. PMID: 36529446 Free article. No abstract available.
Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up.
van Herpen C, Vander Poorten V, Skalova A, Terhaard C, Maroldi R, van Engen A, Baujat B, Locati LD, Jensen AD, Smeele L, Hardillo J, Martineau VC, Trama A, Kinloch E, Even C, Machiels JP; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. van Herpen C, et al. Among authors: even c. ESMO Open. 2022 Dec;7(6):100602. doi: 10.1016/j.esmoop.2022.100602. Epub 2022 Nov 2. ESMO Open. 2022. PMID: 36567082 Free PMC article.
Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022].
van Herpen C, Vander Poorten V, Skalova A, Terhaard C, Maroldi R, van Engen A, Baujat B, Locati LD, Jensen AD, Smeele L, Hardillo J, Costes Martineau V, Trama A, Kinloch E, Even C, Machiels JP; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. van Herpen C, et al. Among authors: even c. ESMO Open. 2023 Oct;8(5):101630. doi: 10.1016/j.esmoop.2023.101630. Epub 2023 Aug 23. ESMO Open. 2023. PMID: 37625197 Free PMC article. No abstract available.
Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations.
Rached L, Laparra A, Sakkal M, Danlos FX, Barlesi F, Carbonnel F, De Martin E, Ducreux M, Even C, Le Pavec J, Michot JM, M Ribeiro J, Scotte F, Ponce Aix S, Lambotte O, Baldini C, Champiat S. Rached L, et al. Among authors: even c. Cancer Treat Rev. 2024 Jun;127:102751. doi: 10.1016/j.ctrv.2024.102751. Epub 2024 May 4. Cancer Treat Rev. 2024. PMID: 38729086 Free article. Review.
Twelve years after: The french national network on rare head and neck tumours (REFCOR).
Gasne C, Atallah S, Dauzier E, Thariat J, Fakhry N, Verillaud B, Classe M, Vergez S, Moya-Plana A, Costes-Martineau V, Righini C, de Gabory L, Digue L, Dupin C, Ferrand FR, Even C, Baujat B; REFCOR members. Gasne C, et al. Among authors: even c. Oral Oncol. 2024 Apr;151:106762. doi: 10.1016/j.oraloncology.2024.106762. Epub 2024 Mar 20. Oral Oncol. 2024. PMID: 38513311 Free article.
202 results